MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announced today that it has filed a patent infringement lawsuit against Aobious, Inc. to protect its intellectual property rights regarding ...
The luciferase assays market is divided geographically into seven regions: Asia-Pacific (excluding Japan), Eastern Europe, Western Europe, North America, Latin America, Middle East & Africa, and ...
MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announces the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase ...
Promega Corporation has announced the launch of the new Nano-Glo® Dual-Luciferase® Reporter (NanoDLR™) Assay, a two-reporter system that incorporates NanoLuc® luciferase technology, providing ...
De novo enzyme design has been used, primarily, in efforts to introduce active sites and substrate-binding pockets. Now, for the first time, scientists have used machine learning to create brand-new ...
NanoLuc ® Binary Technology, also known as NanoBiT, is an innovative binary complementation solution built on NanoLuc® Luciferase (1). As a 19 kDa enzyme, NanoLuc ® Luciferase generates extremely ...
Bioluminescent RNA lanterns have revolutionized the way researchers track RNA activity within living organisms. In a ...
AMES, Iowa -- This year's Nobel Prize for chemistry was given to researchers for their work on illuminating living cells that enables scientists and researchers to study how genes, proteins, and ...
Furimazine substrates are protected by multiple active patents held by Promega. MADISON, Wis., March 05, 2025--(BUSINESS WIRE)--Promega Corporation announced today that it has filed a patent ...